Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,975Revenue (TTM) $M169Net Margin (%)-35.0Altman Z-Score-0.9
Enterprise Value $M2,188EPS (TTM) $-0.3Operating Margin %-99.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.5Pre-tax Margin (%)-36.1Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsN
Price/Sales11.65-y EBITDA Growth Rate %--Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-10.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M193ROIC % (ttm)-140.4Gross Margin Increase y-yY

Gurus Latest Trades with ARIA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARIAMichael Price 2016-03-31 Add0.23%$4.48 - $6.66
($5.6)
$ 10.2583%Add 31.10%1,075,000
ARIAMichael Price 2015-12-31 Add0.08%$5.78 - $7.19
($6.57)
$ 10.2556%Add 14.45%820,000
ARIAMichael Price 2015-09-30 Add0.15%$5.81 - $9.89
($7.71)
$ 10.2533%Add 30.27%716,500
ARIAJoel Greenblatt 2015-06-30 Sold Out $7.9 - $9.71
($8.83)
$ 10.2516%Sold Out0
ARIAMichael Price 2015-03-31 Buy 0.6%$6.1 - $8.97
($7.39)
$ 10.2539%New holding550,000
ARIAJoel Greenblatt 2015-03-31 Buy $6.1 - $8.97
($7.39)
$ 10.2539%New holding16,344
ARIAGeorge Soros 2014-12-31 Sold Out -0.01%$5.02 - $7.46
($6.28)
$ 10.2563%Sold Out0
ARIAGeorge Soros 2014-09-30 Reduce-0.04%$5.01 - $6.5
($5.84)
$ 10.2576%Reduce -85.00%150,000
ARIAGeorge Soros 2014-06-30 Add0.02%$6.3 - $8.52
($6.89)
$ 10.2549%Add 100.00%1,000,000
ARIAGeorge Soros 2014-03-31 Reduce-0.08%$6.46 - $8.99
($7.75)
$ 10.2532%Reduce -74.36%500,000
ARIAGeorge Soros 2013-12-31 Buy 0.11%$2.2 - $18.8
($5.16)
$ 10.2599%New holding1,950,000
ARIAGeorge Soros 2012-06-30 Sold Out -0.15%$14.6 - $17.82
($16.35)
$ 10.25-37%Sold Out0
ARIAGeorge Soros 2012-03-31 Buy 0.15%$12.73 - $16.32
($13.74)
$ 10.25-25%New holding635,000
ARIAGeorge Soros 2011-12-31 Sold Out -0.07%$8.03 - $12.5
($10.96)
$ 10.25-6%Sold Out0
ARIAGeorge Soros 2011-09-30 Buy 0.07%$7.63 - $13.34
($10.54)
$ 10.25-3%New holding496,847
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARIA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARIA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-08-22Sell19,436$10.47-2.58view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-08-12Sell25,000$10.5-2.86view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-07-22Sell18,286$8.1125.77view
Cole Hugh MSVP, Chief Business Officer 2016-06-28Sell6,012$7.0544.68view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-06-22Sell23,999$7.2840.11view
LAVIDAS ATHANESEDirector 2016-06-15Sell76,250$8.2124.24view
Radaelli MassimoDirector 2016-06-14Sell108,569$8.2523.64view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-05-23Sell17,762$8.0826.24view
Panayiotopoulos ParisPresident and CEO 2016-05-12Buy26,990$7.4137.65view
CLACKSON TIMOTHY PPresident, R&D, CSO 2016-05-02Sell11,700$7.1343.06view

Quarterly/Annual Reports about ARIA:

News about ARIA:

Articles On GuruFocus.com
Michael Price Invests in 11 Companies in First Quarter May 19 2015 
Sarah Ketterer of Causeway Capital's Answers to GuruFocus Q&A Apr 07 2014 
Weekly CEO Sells Highlight: U.S. Bancorp, Restoration Hardware Holdings Inc, Ariad Pharmaceuticals, Jul 20 2013 
Daniel Loeb's Top Three Increases of the First Quarter May 24 2013 
Weekly CFO Sales Highlight: WWWW, FIO, CRIS, ARIA, VOG, APKT Apr 22 2012 
3 Biotech Stocks To Consider Buying Right Now Jan 10 2012 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
ARIAD Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 10 2009 
Weekly CEO Buys Highlight: Citigroup Inc, ARIAD Pharmaceuticals Inc, Bruker BioSciences Corp, Akamai Aug 08 2009 

More From Other Websites
ETF’s with exposure to ARIAD Pharmaceuticals, Inc. : August 24, 2016 Aug 24 2016
ARIAD PHARMACEUTICALS INC Financials Aug 17 2016
Why There Is Upside for Incyte Despite Recent Selloff Aug 09 2016
ARIAD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 08 2016
ETF’s with exposure to ARIAD Pharmaceuticals, Inc. : August 8, 2016 Aug 08 2016
ARIAD Pharmaceuticals, Inc. :ARIA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 Aug 05 2016
PDL BioPharma Completes Second Tranche Payment Under Royalty Transaction with ARIAD Pharmaceuticals Aug 01 2016
PDL BioPharma Completes Second Tranche Payment Under Royalty Transaction with ARIAD Pharmaceuticals Aug 01 2016
ARIAD's (ARIA) Stock Up on Q2 Earnings & Revenue Beat Jul 29 2016
Today’s Trending Stocks: Pioneer, Ariad, Hershey, and 2 More Jul 28 2016
ARIAD (ARIA) Stock Pops After Q2 Beat Jul 28 2016
ARIAD (ARIA) Swings to Earnings in Q2, Revenues Beat Jul 28 2016
Ariad beats 2Q profit forecasts Jul 28 2016
Ariad beats 2Q profit forecasts Jul 28 2016
ARIAD Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Jul 28 2016
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 28 2016
ARIAD Reports Second Quarter and First Half 2016 Financial Results Jul 28 2016
Q2 2016 ARIAD Pharmaceuticals Inc Earnings Release - Before Market Open Jul 28 2016
Watch for Drug Stocks Earnings on Jul 28: BMY, CELG & More Jul 27 2016
ARIAD (ARIA) to Report Q2 Earnings: Will the Stock Surprise? Jul 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)